This Fund Manager Rating is based on the Citywire Long Only ratings methodology
Citywire Ratings are rewarded for risk adjusted outperformance of benchmarks we select independently More information on how Ratings are calculated
About Ivo Staijen
HBM Partners' Ivo Staijen has over four years of experience in the pharma industry and over fourteen years of experience in investment analysis and portfolio management in the healthcare sector. He is also a former senior biotechnology analyst at Bank Sarasin and a former department head at MDS Pharma Services. Ivo has a Master of Science degree in chemistry from the University of Groningen, the Netherlands, and a PhD in biology from the Swiss Federal Institute of Technology (ETH), in Zurich, Switzerland. He also was a visiting scholar at the Department of Biology at the MIT, Cambridge, Massachusetts USA.
Citywire Rating: AA rated
|4||Rudi Van den Eynde||10.3%|
|View full league table|
Month by Month Performance